Last reviewed · How we verify

NCT07018414

Abdominal Massage for Gastric Residual Volume in Surgical Patients

Completed NA Last updated 12 June 2025
What this trial tests

NA trial testing Abdominal Massage in Gastric Residual Volume in 84 participants. Completed in 5 April 2025.

Timeline
5 April 2024
Primary endpoint
5 April 2025
5 April 2025

Quick facts

Lead sponsorMarmara University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment84
Start date5 April 2024
Primary completion5 April 2025
Estimated completion5 April 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University

Who can join

Eligibility, any sex, with Gastric Residual Volume or Abdominal Distension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled trial aimed to evaluate the effect of abdominal massage on gastric residual volume (GRV) and abdominal distension in surgical intensive care patients receiving enteral nutrition. The intervention group received 20-minute abdominal massage sessions twice daily for 3 consecutive days. Outcomes included changes in GRV, abdominal circumference, feeding volume, and gastrointestinal tolerance parameters.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Abdominal Massage

Trials testing the same drug.

Other recruiting trials for Gastric Residual Volume

Currently open trials in the same condition.

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07018414.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing